Author: admin

CHDS faculty Ankur Pandya outlined how economic evaluation methods could be used to improve the process of making difficult policy choices around COVID-19 in a recently co-authored 

Steven Pearson spoke about the role of the Institute for Clinical and Economic Review (ICER) in encouraging the consideration of cost-effectiveness in US drug policy in a recent CHDS seminar.

A recent study by CHDS Research Scientist Shafika Abrahams-Gessel and faculty Thomas A. Gaziano showed that federal food service guidelines improve health outcomes and are cost-saving. Despite

Nathaniel Hendrix, CHDS faculty Stéphane Verguet, and colleagues performed a systematic review of cost-effectiveness analyses that assessed activities designed to strengthen health

Alicia Yamin spoke about her work on fostering meaningful citizen participation in health priority setting during a recent CHDS seminar. Yamin is a lecturer on Law and Senior Fellow on Global Health and

CHDS Deputy Director Lisa Robinson was named a Fellow by the Society for Benefit-Cost Analysis, the Society’s highest award for contributions to theory and practice, at its March 2022 Annual Conference

Anna Vassall shared her experiences in supporting policy decisions throughout different phases of the Covid-19 pandemic in a recent CHDS seminar. Vassall directs the Global Health

A new interactive webtool can estimate future U.S. tuberculosis (TB) and latent TB infection (LTBI) cases in US states. Nicole Swartwood, Research Analyst in CHDS Faculty Nicolas Menzies’ lab, is leading

CHDS Deputy Director Lisa A. Robinson will lead her professional development course, Benefit-Cost Analysis: Valuing Life and Health online from September 19 through 23, 2022. Benefit-cost analysis is an

CHDS Senior Research Scientist Nicole Campos ’ modeling study shows that cervical cancer screening uptake among African-American women in the Mississippi Delta may improve and be cost-effective